These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 345749)

  • 21. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of the antiparkinsonian drugs on the plasma level of neuroleptics.
    Gautier J; Jus A; Villeneuve A; Jus K; Pires P; Villeneuve R
    Biol Psychiatry; 1977 Jun; 12(3):389-99. PubMed ID: 871490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of neuroleptic drug action, particularly considering butyrophenones.
    Kristjansen P
    Acta Psychiatr Scand Suppl; 1966; 191():171-7. PubMed ID: 5336724
    [No Abstract]   [Full Text] [Related]  

  • 29. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 30. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 31. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs.
    Sedvall G; Fyrö B; Nybäck H; Wiesel FA; Wode-Helgodt B
    J Psychiatr Res; 1974; 11():75-80. PubMed ID: 4461807
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 34. Voltage laterality in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1973 Mar; 34(3):190-1. PubMed ID: 4715636
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
    Wålinder J; Skott A; Carlsson A; Roos BE
    Arch Gen Psychiatry; 1976 Apr; 33(4):501-5. PubMed ID: 779704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
    Overall JE; Hollister LE; Prusmack JJ; Shelton J; Pokorny A
    J Clin Pharmacol J New Drugs; 1969; 9(5):328-38. PubMed ID: 4899114
    [No Abstract]   [Full Text] [Related]  

  • 37. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA; Laughren T; Chisholm E; Williams BW
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative double blind study between chlozapine and chlorpromazine in schizophrenia].
    Ruíz Ruíz M
    Arch Neurobiol (Madr); 1974 Mar; 37(2):169-80. PubMed ID: 4600866
    [No Abstract]   [Full Text] [Related]  

  • 39. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
    Kane J; Honigfeld G; Singer J; Meltzer H
    Arch Gen Psychiatry; 1988 Sep; 45(9):789-96. PubMed ID: 3046553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers.
    Nishikawa T; Tsuda A; Tanaka M; Koga I; Uchida Y
    Biol Psychiatry; 1985 Nov; 20(11):1161-6. PubMed ID: 3902105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.